[Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain]
- PMID: 36709415
- PMCID: PMC10066906
- DOI: 10.37201/req/102.2022
[Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain]
Abstract
Objective: To analyze the frequency of influenza and SARS-CoV-2 co-infections, as well as the differences in the course of disease (risk of mortality, hospital and intensive care admissions) in patients infected with the SARS-CoV-2 virus in relation to flu vaccination status in the 2021-2022 season.
Methods: Population-based observational retrospective study in a cohort of 19,850 patients diagnosed with COVID-19 between June 1, 2021 and February 28, 2022 on the island of Gran Canaria.
Results: A total of 1,789 patients (9%) diagnosed with COVID-19 had received flu vaccinations. 13,676 people (68.9%) had a full course of COVID-19 vaccinations. In the period between June 1, 2021 and February 28, 2022, 8 cases of flu and COVID-19 coinfection were recorded. Hypertension (18.5%), asthma (12.8%) and diabetes (7.2%) were the most frequent comorbidities. There were 147 deaths (0.7%). Older patients ([OR] 1.11 95% CI 1.09-1.13) and people with cancer ([OR] 4.21 95% CI 2.58-6.89) had a higher risk of dying from COVID-19 (p<0.05). Female sex was noted as a protective factor ([OR] 0.61 95% CI 0.40-0.92).
Conclusions: Old age, male sex and cancer were independent prognostic factors for mortality. Three doses of SARS-CoV-2 vaccines and influenza vaccines were highly effective in preventing COVID-19-related deaths and hospital admissions. These findings suggest that flu vaccination can help control the pandemic.
Objetivo: Analizar la frecuencia de coinfecciones entre los virus gripales y el SARS-CoV-2, además de las diferencias en la evolución (riesgo de mortalidad, ingreso hospitalario o en intensivos) de los pacientes infectados por el virus del SARSCoV-2 según vacunación o no vacunación de la gripe en la temporada 2021-2022.
Método: Estudio retrospectivo observacional de base poblacional en una cohorte de 19.850 pacientes diagnosticados de COVID-19 entre el 1 de junio de 2021 y 28 de febrero de 2022 en la isla de Gran Canaria.
Resultados: Fueron vacunados de la gripe 1.789 personas, el 9% del total de pacientes diagnosticados de COVID-19. 13.676 personas (68,9%) contaban con pauta completa de vacunación del COVID-19. En el periodo comprendido entre el 1 de junio de 2021 y 28 de febrero de 2022 se registraron 8 casos de coinfección gripe y COVID-19. Hipertensión (18,5%), asma (12,8%) y diabetes (7,2%) fueron las comorbilidades más frecuentes. Hubo 147 defunciones (0,7%). Las personas de mayor edad ([OR] 1,11 IC 95% 1,09-1,13) y con cáncer ([OR] 4,21 IC 95% 2,58-6,89) tuvieron mayor riesgo de fallecer por COVID-19 (p<0,05). El sexo femenino fue considerado un factor protector ([OR] 0,61 IC 95% 0,40-0,92).
Conclusiones: La edad avanzada, el sexo masculino y el cáncer fueron factores pronósticos independientes de mortalidad. Tres dosis de la vacuna del SARS-CoV-2 y la vacuna de la gripe fueron altamente efectivas para prevenir muertes e ingresos relacionados con COVID-19. Estos hallazgos sugieren que la vacunación contra la gripe puede ayudar a controlar la pandemia.
Keywords: COVID-19; Influenza; immunity; infection; vaccine.
©The Author 2023. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Conflict of interest statement
Los autores declaran no tener conflicto de intereses.
Figures
Similar articles
-
Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.Vaccine. 2024 Feb 15;42(5):1184-1192. doi: 10.1016/j.vaccine.2023.12.084. Epub 2024 Jan 30. Vaccine. 2024. PMID: 38296701 Free PMC article.
-
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36274602 Chinese.
-
Evaluation of persistent COVID and SARS-CoV-2 reinfection in a cohort of patients on the island of Gran Canaria, Spain.Semergen. 2023 Jul-Aug;49(5):101939. doi: 10.1016/j.semerg.2023.101939. Epub 2023 Jan 25. Semergen. 2023. PMID: 36889055 Free PMC article.
-
[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Feb 6;56(2):103-107. doi: 10.3760/cma.j.cn112150-20211203-01117. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 34954956 Review. Chinese.
-
SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective.Cell Biol Int. 2022 Jul;46(7):1009-1020. doi: 10.1002/cbin.11800. Epub 2022 Apr 2. Cell Biol Int. 2022. PMID: 35322909 Free PMC article. Review.
References
-
- WHO Coronavirus (COVID-19) Dashboard. (Accessed November 03, 2022). Available at: https://covid19.who.int
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous